68 search results for: asthma

Adult <b>Asthma</b> Interactive Patient Cases
Pulmonology
Adult Asthma Interactive Patient Cases
interactivity

Explore 3 hypothetical patient cases using guideline-based checklists for assessment and diagnosis of type 2 inflammation in adult asthma

View more
Pediatric <b>Asthma</b> Patient Case Tool: Ash
Pulmonology
Pediatric Asthma Patient Case Tool: Ash
interactivity

Review a patient case to learn more about identifying uncontrolled asthma and type 2 inflammation in pediatric patients

View more
ADVENT On Air | Disease Modification in Severe <b>Asthma</b>: Framework, Assessment, and Clinical Impact
Pulmonology
ADVENT On Air | Disease Modification in Severe Asthma: Framework, Assessment, and Clinical Impact
Podcast

Join Professors Brusselle and Backer as they discuss the concept of disease modification in asthma.

View more
COPD and <b>Asthma</b>: What's the Difference and Is There a Link?
Pulmonology
COPD and Asthma: What's the Difference and Is There a Link?
interactivity

Explore the characteristics of COPD and asthma, focusing on their shared inflammatory mechanisms and key clinical differences.

View more
Spotlight on Type 2 Inflammation in the Upper and Lower Airways
Pulmonology
Spotlight on Type 2 Inflammation in the Upper and Lower Airways
expert video

In this video soundbite from the EAACI 2025 symposium, Dr. Zuzana Diamant explains pathophysiological mechanisms underlying asthma and CRSwNP, and how type 2 inflammatory cytokines drive airway remodelling in patients with severe asthma. Additionally, patients with co-existing asthma and CRSwNP have a higher type 2 inflammatory burden than patients with asthma alone.

View more
Head-to-Head Trials of Biologics in CRSwNP
Rhinology
Head-to-Head Trials of Biologics in CRSwNP
expert video

In this video soundbite from the ERS-ISIAN 2025 symposium, Dr. Sietze Reitsma discusses findings from the EVEREST trial, the first head-to-head study comparison of dupilumab and omalizumab in patients with severe CRSwNP and coexisting asthma. It also introduces the ongoing TORNADO study.

View more
How Can FeNO Measurement Improve Severe <b>Asthma</b> Management?
Pulmonology
How Can FeNO Measurement Improve Severe Asthma Management?
expert video

Join Dr. Miguel Lanz as he explains the clinical utility of FeNO as a biomarker of severe asthma.

View more
ERS 2024 | Pathophysiologic Mechanisms of Airway Remodeling in Severe <b>Asthma</b>
Pulmonology
ERS 2024 | Pathophysiologic Mechanisms of Airway Remodeling in Severe Asthma
expert video

Professor Celeste Porsbjerg presents the pathophysiology and disease processes involved in airway remodeling in severe asthma.

View more
ERS 2026
Congress
5
September
2026
Congress
ADVENT at ERS 2026

Join Sanofi and Regeneron for four educational symposia on asthma, COPD, and the unified airway.

ADVENT On Air | Diving Deep: Exploring the Impact of Airway Remodeling in Severe <b>Asthma</b>
Pulmonology
ADVENT On Air | Diving Deep: Exploring the Impact of Airway Remodeling in Severe Asthma
Podcast

Join Dr. Mario Castro and Prof. Vibeke Backer as they discuss airway remodeling and airway hyperresponsiveness and their impact in the lives of patients with severe asthma.

View more
Compounded Burden of Co-existing Type 2 Airway Diseases
Pulmonology
Compounded Burden of Co-existing Type 2 Airway Diseases
expert video

In this video soundbite from the EAACI 2025 symposium, Dr. Brian Lipworth discusses that co-existing type 2 inflammatory diseases are common in patients with CRSwNP​ & increasing severity of asthma is associated with higher severity of CRS and prevalence of nasal polyps. Additionally, he explains that patient burden is substantially greater when asthma and CRSwNP are co-existing.

View more
EAACI 2024 | On-Treatment Clinical Remission in Upper and Lower Airways: ​ Going Beyond Symptom Control​
Congress
31
May
2024
Congress
EAACI 2024 | On-Treatment Clinical Remission in Upper and Lower Airways: ​ Going Beyond Symptom Control​

Join experts G. Walter Canonica, Vibeke Backer, and Joaquim Mullol for an educational symposium on elevating treatment goals from control to remission in the upper and lower airways.